Overview of Malignant Brain Tumour
Overview of Malignant Brain Tumour A malignant brain tumour is a life-threatening growth of abnormal cells within the brain or its surrounding structures. Unlike benign brain tumours, which grow slowly and usually stay in one place, malignant tumours are cancerous. They grow rapidly, invade nearby tissue, and may spread within the brain or spinal cord. These tumours interfere with critical brain functions. Even small tumours can cause serious issues due to the limited space inside the skull. They can affect movement, memory, speech, and other essential functions. Malignant brain tumours are either primary, meaning they start in the brain, or secondary (metastatic), meaning they spread from cancer in another part of the body. While brain cancers are relatively rare, they cause a disproportionate amount of disability and cancer-related deaths due to their aggressive nature. This section provides an overview of malignant brain tumour, including its definition, types, risk factors, symptoms, and classification. What Is a Malignant Brain Tumour? A malignant brain tumour is made up of cancerous cells that: These tumours can disrupt vital brain functions, depending on their location, size, and type. WHO Tumour Grading The World Health Organization (WHO) classifies brain tumours into four grades. Grades III and IV are considered malignant: Primary vs Secondary Brain Tumours Primary Malignant Brain Tumours These tumours originate in the brain or nearby structures like the meninges, cranial nerves, or pituitary gland. Common types include: Primary tumours rarely spread outside the central nervous system but grow invasively within it. Secondary (Metastatic) Brain Tumours These are more common than primary brain cancers. They develop when cancers from other organs spread to the brain, usually via the bloodstream. Epidemiology Risk Factors Most malignant brain tumours appear spontaneously, with no clear cause. However, known or suspected risk factors include: Symptoms and Impact Symptoms of malignant brain tumours vary based on their size, growth rate, and location. Common symptoms include: These symptoms often cause misdiagnosis, delay in treatment, and emotional distress. Classification and Grading The WHO classifies brain tumours using both: This approach offers better accuracy in predicting tumour behaviour and treatment response. Example:Glioblastomas are now classified as WHO Grade IV IDH-wildtype, which signals a poorer prognosis. Diagnostic Challenges Early symptoms of malignant brain tumours are often vague. Accurate diagnosis may involve: Delays in diagnosis are common, especially in older adults, where symptoms may mimic ageing or dementia. Prognosis and Outcomes Survival rates depend on tumour type, location, and how early treatment begins. Even with treatment, high-grade tumours often return. Survivors may live with long-term cognitive or physical impairments. Psychosocial and Economic Impact Malignant brain tumours cause significant emotional, physical, and financial strain: Support services, counselling, and financial assistance are crucial for both patients and families. Summary This overview of malignant brain tumour highlights its severity, complexity, and impact. These tumours are among the hardest to treat due to their aggressive growth, resistance to therapy, and location in the brain. Despite advances in surgery, radiotherapy, and chemotherapy, outcomes remain poor for many high-grade tumours. However, ongoing research in molecular biology and targeted therapies holds promise for the future. In the next section, we will explore the Causes of Malignant Brain Tumour, including known risk factors and emerging research into genetic and environmental links. [Next: Causes of Malignant Brain Tumour →]





